Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating income | -$109M | -$125M | -$247M | -$142M | -$180M | -$141M |
| Net income | -$102M | -$123M | -$243M | -$125M | -$162M | -$125M |
| EPS (diluted) | -$4.83 | -$1.85 | -$1.99 | -$0.83 | -$0.69 | -$0.44 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$32.7M | -$79.6M | -$103M | -$101M | -$109M | -$95.5M |
| Capital expenditures | $947K | $11.2M | $14.6M | $1.77M | $60.0K | $128K |
| Free cash flow | -$33.6M | -$90.8M | -$118M | -$103M | -$109M | -$95.6M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $65.4M | $360M | $284M | $93.1M | $67.7M | $73.8M |
| Total assets | $125M | $501M | $515M | $395M | $503M | $396M |
| Total liabilities | $17.4M | $44.9M | $103M | $78.6M | $79.0M | $71.0M |
| Shareholders' equity | -$114M | $457M | $412M | $317M | $423M | $325M |
| Retained earnings | -$115M | -$238M | -$481M | -$606M | -$768M | -$892M |
| Shares (wtd avg diluted) | 21.9M | 66.3M | 122M | 150M | 234M | 284M |
Every figure is extracted from Erasca, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.